October 2025 in “Diseases” This study reports that women with hair loss had significantly lower levels of several biomarkers, including hemoglobin, iron, copper, selenium, vitamin D, vitamin B12, folate, and thyroid hormones, compared to healthy controls.
August 2025 in “Al-Iraqia Medical College Journal” This study found that among eight RNA viruses, susceptibility to infection is directly related to heat tolerance and virus size, while inversely related to high humidity and mutation rate. Additionally, larger viruses had higher mutation rates.
July 2025 in “Pakistan Journal of Intensive Care Medicine” In this randomized controlled trial, researchers observed that topical clobetasol propionate 0.05% was significantly more effective than topical tacrolimus 0.1% for treating alopecia areata, with a higher treatment success rate of 74.2% versus 45.2%, suggesting clobetasol as a preferred first-line topical therapy.
April 2025 in “ALEXMED ePosters” This study found that nanofat injections significantly improved scar characteristics, including collagen deposition, epidermal thickness, and vascularity, due to its anti-inflammatory and immunomodulatory properties.
March 2025 in “Journal of College of Physicians And Surgeons Pakistan” In this cross-sectional survey conducted in Lahore, Pakistan, 64% of LGBTQ participants experienced dermatological conditions such as androgenic alopecia, atopic eczema, melasma, and infections like scabies, highlighting the need for specialized dermatological care within this community.
February 2025 in “American Journal of Medical Case Reports” The case report highlights the diagnostic challenges of low-grade trichoblastic carcinoma, a rare malignant tumor often mistaken for benign lesions, in a 51-year-old female with immunocompromising conditions. Accurate diagnosis relied on histopathological examination, and achieving clear surgical margins was crucial to prevent recurrence.
April 2024 in “Skin health and disease” In this case study, a patient developed parieto-temporal pain, tissue necrosis, and alopecia after receiving a hyaluronic acid injection for temporal augmentation, which was effectively treated with hyaluronidase and aspirin.
In this case report, off-label onabotulinumtoxin-A was successfully used to treat trichodynia, a painful scalp sensation associated with hair loss, in a patient unresponsive to conventional therapies.
March 2024 in “Clinical, Cosmetic and Investigational Dermatology” Among Saudi dermatologists, this study reported widespread recognition of low-dose oral minoxidil's use for patterned hair loss and its side effect of hypertrichosis; however, many avoid prescribing it due to its unavailability in local pharmacies.
December 2023 in “Journal of family medicine and primary care” This study in Saudi Arabia found that 59.70% of participants experienced hair shedding during or after COVID-19, with significant risk factors including being female, having a history of telogen effluvium, and receiving COVID-19 antiviral treatment.
October 2023 in “CHEST Journal” This case report illustrates that diffuse alveolar hemorrhage can be a serious initial manifestation of systemic lupus erythematosus, characterized by progressive dyspnea, hemoglobin decrease, and respiratory symptoms.
October 2023 in “Journal of Family Medicine and Primary Care” This survey in Riyadh Province found that most participants identified malnutrition as the leading cause of iron deficiency anemia and reported symptoms like weakness and cold extremities.
June 2023 in “Dermatology and therapy” This study found that most dermatologists in the Middle East manage mild to severe alopecia areata primarily with potent topical corticosteroids and identified long-term disease control and improved efficacy as key unmet needs.
September 2022 in “JAMC. Journal of Ayub Medical College, Abbotabad, Pakistan/Journal of Ayub Medical College” This case study reports that zinc supplementation significantly improved the symptoms of Acrodermatitis Enteropathica in a 12-year-old boy, emphasizing the importance of early diagnosis and treatment compliance.
This study found that liquid nitrogen cryotherapy significantly improved alopecia areata in 27.4% of treated patients after six weeks, with no association between treatment efficacy and factors like age or gender.
November 2021 in “World Family Medicine Journal /Middle East Journal of Family Medicine” In this study, levothyroxine therapy showed no significant effect on blood sugar level changes in children with growth hormone deficiency in Saudi Arabia.
February 2019 in “International journal of scientific reports” This case study observed that Unani medicine appeared effective for hair regrowth in a 16-year-old with alopecia areata after 45 days of treatment.
January 2019 in “Global Dermatology” This review discusses the genetic disorder, monilethrix, characterized by fragile, brittle hair and its inheritance patterns, and reports no new clinical results.
September 2018 in “Cumhuriyet medical journal” This study found that women with severe hirsutism have thicker subcutaneous abdominal fatty tissue and are more likely to develop metabolic syndrome compared to those with moderate hirsutism.
January 2018 in “Biomedical Research (Aligarh)” This study found no significant differences in bone mineral density or predisposing factors across hair-loss stages in women with androgenetic alopecia, though early-onset cases may warrant investigation for premature bone loss.
July 2016 in “Cancer Research” This study developed a topical botanical lotion for managing chemotherapy-induced hair loss in cancer patients, reporting that it improved hair recovery times by 5-16 weeks, reduced inflammation, and enhanced scalp collagen levels with no observed side effects.
April 2016 in “Journal of Investigative Dermatology” In this study, three patients with extensive alopecia areata receiving ustekinumab treatment showed significant hair regrowth and decreased inflammation over 20 weeks, suggesting potential targeted treatment for this condition.
December 2015 in “Journal of Psoriasis and Psoriatic Arthritis” This case report describes a rare instance of prolonged alopecia following acitretin therapy where the patient's hair did not significantly regrow more than six months after stopping treatment.
May 2015 in “Cancer Research” This study found that a new treatment candidate may effectively prevent and promote recovery from chemotherapy-induced alopecia by normalizing apoptosis and reducing inflammation in cancer patients.
October 2014 in “Cancer Research” This study observed that applying a GMP-grade botanical extract to the scalp increased Bcl-2 levels, potentially preventing premature hair follicle apoptosis in chemotherapy and radiotherapy-induced alopecia.
April 2013 in “Cancer Research” This study found that a botanical extract increased Bcl-2 levels and improved the anagen-to-telogen hair ratio in men with androgenetic alopecia, suggesting potential for managing chemotherapy-induced alopecia.
March 2023 in “The Journal of Urology” This study observed that despite the increase in nocturia cases from 2016 to 2021, the use of pharmacotherapy for the condition declined, suggesting potential undertreatment.
January 2021 in “Esculapio” This study found that autologous platelet-rich plasma treatment significantly increased the number of hairs in male patients with androgenetic alopecia.
253 citations
,
December 2007 in “Journal of Investigative Dermatology” This study suggests that human hair follicles may actively suppress natural killer cells, which contrasts with the observed defects in NK cell regulation in alopecia areata.
188 citations
,
February 2023 in “International Journal of Molecular Sciences” This review compiled evidence suggesting that flavonoids may promote skin wound healing due to their anti-inflammatory, angiogenesis, re-epithelialization, and antioxidant properties, while also discussing current limitations and future prospects for these compounds as wound-healing agents.